The Membrane Protein Alkaline Phosphatase Is Delivered to the Vacuole by a Route That Is Distinct from the VPS-dependent Pathway by Piper, Robert C. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/97/08/531/15 $2.00
The Journal of Cell Biology, Volume 138, Number 3, August 11, 1997 531–545
http://www.jcb.org 531
 
The Membrane Protein Alkaline Phosphatase
Is Delivered to the Vacuole by a Route
That Is Distinct from the 
 
VPS
 
-dependent Pathway
 
Robert C. Piper, Nia J. Bryant, and Tom H. Stevens
 
Institute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229
 
Abstract. 
 
Membrane trafficking intermediates in-
volved in the transport of proteins between the TGN 
and the lysosome-like vacuole in the yeast 
 
Saccharomy-
ces cerevisiae
 
 can be accumulated in various 
 
vps
 
 mu-
tants. Loss of function of Vps45p, an Sec1p-like protein 
required for the fusion of Golgi-derived transport vesi-
cles with the prevacuolar/endosomal compartment 
(PVC), results in an accumulation of post-Golgi trans-
port vesicles. Similarly, loss of 
 
VPS27
 
 function results 
in an accumulation of the PVC since this gene is re-
quired for traffic out of this compartment.
The vacuolar ATPase subunit Vph1p transits to the 
vacuole in the Golgi-derived transport vesicles, as de-
fined by mutations in 
 
VPS45
 
, and through the PVC, as 
defined by mutations in 
 
VPS27.
 
 In this study we dem-
onstrate that, whereas 
 
VPS45
 
 and 
 
VPS27
 
 are required 
for the vacuolar delivery of several membrane proteins, 
the vacuolar membrane protein alkaline phosphatase 
(ALP) reaches its final destination without the function 
of these two genes. Using a series of ALP derivatives, 
we find that the information to specify the entry of 
ALP into this alternative pathway to the vacuole is con-
tained within its cytosolic tail, in the 13 residues adja-
cent to the transmembrane domain, and loss of this 
sorting determinant results in a protein that follows the 
 
VPS
 
-dependent pathway to the vacuole.
Using a combination of immunofluorescence local-
ization and pulse/chase immunoprecipitation analysis, 
we demonstrate that, in addition to ALP, the vacuolar 
syntaxin Vam3p also follows this 
 
VPS45/27
 
-indepen-
dent pathway to the vacuole. In addition, the function 
of Vam3p is required for membrane traffic along the 
 
VPS
 
-independent pathway.
 
T
 
he
 
 sorting and delivery of vacuolar hydrolases in
the yeast 
 
Saccharomyces cerevisiae
 
 has become an
important model system of membrane trafficking
that parallels lysosomal biogenesis in animal cells (Korn-
feld and Mellman, 1989; Rothman et al., 1989; Mellman,
1990; Conibear and Stevens, 1995). Current data support a
model whereby a receptor (Vps10p) recognizes soluble
vacuolar hydrolases such as carboxypeptidase (CPY)
 
1
 
 in
the late Golgi apparatus. This receptor/ligand complex de-
parts the Golgi apparatus and is delivered to a prevacu-
olar/endosomal compartment (PVC) where the receptor
dissociates from CPY and recycles back to the Golgi appa-
ratus. Soluble hydrolases as well as endocytosed proteins
that are delivered to the PVC then move on to the vacuole
(for review see Horazdovsky et al., 1995).
Many nonessential genes that play a role in the delivery
of proteins to the yeast vacuole have been identified.
These 
 
VPS
 
 genes (Vacuolar Protein Sorting) were identi-
fied by isolating yeast mutants that secrete CPY instead of
efficiently sorting and delivering it to the vacuole (Bankai-
tis et al., 1986; Rothman et al., 1989; Stack et al., 1995).
Mutations in many of these genes have provided tools to
map out the vacuolar biogenesis pathway described above.
Loss of function mutations in many of these genes result in
the accumulation of the membrane transport intermedi-
ates that appear to play a central role in the transport of
proteins to the vacuole.
One of these intermediates is a class of transport vesi-
cles controlled by a group of 
 
VPS
 
 genes termed class D
(Raymond et al., 1992), which includes 
 
PEP12
 
 (a syntaxin
homologue) (Becherer et al., 1996), 
 
VPS21/YPT51
 
 (an
Rab5 homologue) (Horazdovsky et al., 1994; Singer-Kruger
et al., 1994), and 
 
VPS45
 
 (an 
 
SEC1
 
 homologue) (Cowles et
al., 1994; Piper et al., 1994). Since cells with null alleles in
any of the above class D genes accumulate many small
vesicles within the cytoplasm, these genes are thought to
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1.
 
 Abbreviations used in this paper
 
: ALP, alkaline phosphatase; CPY, car-
boxypeptidase Y; DPAP, dipeptidyl aminopeptidase; 5-FOA, 5-fluoro-
orotic acid; ORF, open reading frame; PVC, prevacuolar/endosomal com-
partment; YPD, 1% yeast extract, 1% peptone, 2% dextrose.
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act together to effect a vesicle fusion event along the vacu-
olar biogenesis pathway. Furthermore, cells carrying a
temperature-sensitive allele of 
 
VPS45
 
 rapidly accumulate
these 
 
z
 
60–70-nm transport vesicles concomitant with a
loss of the ability to sort CPY upon shifting cells to the
nonpermissive temperature (Piper et al., 1994). Epistasis
studies together with the ability of these accumulated vesi-
cles to trap anterograde traffic en route to the vacuole
(Piper, R.C., and T.H. Stevens, unpublished observations)
support the idea that these class D Vps proteins allow
the fusion of Golgi-derived transport vesicles with the
prevacuolar compartment (Conibear and Stevens, 1995;
Horazdovsky et al., 1995). 
Transit through the PVC appears to be controlled by a
different set of 
 
VPS
 
 genes, the class E 
 
VPS
 
 genes (Ray-
mond et al., 1992). Cells carrying a temperature-sensitive
allele of one of these class E genes, 
 
VPS27
 
, rapidly and re-
versibly accumulate cycling Golgi proteins (such as Vps10p),
endocytosed proteins (such as Ste3p), and vacuolar pro-
teins in a large, exaggerated form of the PVC (termed the
“class E” compartment) (Piper et al., 1995). The accumu-
lation of the prevacuolar compartments into the character-
istic class E compartment results from the decreased abil-
ity of proteins to depart this compartment and either to
move on to the vacuole or to return to the Golgi (Ray-
mond et al., 1992; Piper et al., 1995). Together, the 
 
vps45
 
and 
 
vps27
 
 mutations can be used to define intermediates
that lie along the vacuolar biogenesis pathway from the
late Golgi to the vacuole and that are responsible for the
delivery of soluble hydrolases such as CPY as well as
membrane proteins such as Vph1p (a subunit of the vacu-
olar H
 
1
 
-ATPase).
Yet another route from Golgi to the vacuole is taken by
proteins such as Ste2p, Ste3p, and Ste6p (Davis et al.,
1993; Berkower et al., 1994). All of these membrane pro-
teins transit to the plasma membrane, whereupon they are
endocytosed and delivered to the vacuole (Singer and
Riezman, 1990; Davis et al., 1993; Berkower et al., 1994).
Whereas the delivery of these endocytosed proteins is
not blocked by 
 
vps45
 
D
 
 mutations that accumulate Golgi-
derived transport vesicles headed for the prevacuolar
compartment, their delivery to the vacuole is blocked by
 
vps27
 
 mutations, which cause proteins that follow this
route to be trapped in the class E PVC (Piper et al., 1995).
One curious feature of cells carrying either 
 
vps45
 
D
 
,
 
vps27
 
D
 
, or both mutations is that there remains a discern-
ible vacuole. Previous studies have shown that at least one
membrane protein, alkaline phosphatase (ALP), can be
immunolocalized to the vacuole in either 
 
vps45
 
D
 
 or
 
vps27
 
D
 
 cells, whereas other vacuolar membrane proteins
are found in the characteristic post-Golgi intermediates
(Raymond et al., 1992; Piper et al., 1994). This led us to hy-
pothesize that ALP travels from the late Golgi to the vacu-
ole by an alternative route independent of the vacuolar
biogenesis pathway defined to date. In this study we report
that ALP is rapidly and faithfully delivered to the vacuole
independent of Vps45p or Vps27p function. Unlike the
other vacuolar membrane proteins we examined, ALP es-
caped entrapment in the Golgi-derived transport vesicles
in 
 
vps45
 
 mutant cells or the prevacuolar/endosomal class
E compartment in 
 
vps27
 
 mutant cells. This pathway ap-
pears to be completely intracellular as we did not detect
ALP passing via the plasma membrane in wild-type cells
or cells without Vps45p or Vps27p function. Furthermore,
we find that the sorting determinant within the ALP pro-
tein that allows it to bypass the 
 
VPS45/VPS27
 
-dependent
pathway is contained within its NH
 
2
 
-terminal cytosolic tail.
 
Materials and Methods
 
Materials
 
Enzymes used in DNA manipulations were from New England Biolabs
(Beverly, MA), Boehringer Mannheim Biochemicals (Indianapolis, IN),
GIBCO BRL (Gaithersburg, MD), or United States Biochemical Corp.
(Cleveland, OH). Glutathione agarose beads were from Sigma Chemical
Co. (St. Louis, MO). FITC-conjugated streptavidin, Texas red–conjugated
goat anti–rabbit antibodies, and biotin-conjugated goat anti–rabbit antibod-
ies were purchased from Jackson ImmunoResearch Laboratories, Inc.
(West Grove, PA). The anti-CPY and anti-ALP polyclonal antibodies
have been previously described (Raymond et al., 1990; Cooper and
Stevens, 1996). The anti-Vma2p mAb, 13D11B2, has been reported (Ray-
mond et al., 1992). The anti-ALP mAb 1D3 (Molecular Probes, Eugene,
OR) and the anti–dipeptidyl aminopeptidase (DPAP) B antibody were
used as previously described (Cooper and Stevens, 1996; Roberts et al.,
1989). The rabbit polyclonal anti-Vam3p antibody was raised against the
cytosolic NH
 
2
 
-terminal domain of Vam3p in the context of a glutathione-
S-transferase fusion protein expressed from the plasmid pRCP160. Fixed
 
Staphylococcus aureus
 
 cells (IgG Sorb) were obtained from The Enzyme
Center (Malden, MA). 
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S-Express label was from New England Nuclear
(Boston, MA). Oxalyticase was from Enzogenetics (Corvallis, OR). All
other chemicals were of high purity commercial grade.
 
Plasmid Construction
 
Plasmids used in this study are listed in Table I. The 
 
GAL1-VPH1
 
 inte-
grating construct, pLG39, was made by first subcloning the DraI fragment
of 
 
VPH1
 
, (encompassing the 
 
VPH1
 
 open reading frame [ORF]) behind
the 
 
GAL1
 
 promoter in the BamHI site of pCJR52 to yield pLG1. pCJR52
was made by subcloning an EcoRI/BamHI fragment encoding the 
 
GAL1
 
promoter into the CEN-based 
 
URA3
 
 plasmid, pSEYC68 (Herman and
Emr, 1990). The EcoRI fragment from pLG1 (containing the 
 
GAL1
 
 pro-
moter and codons 1–707 of 
 
VPH1
 
) was subcloned into pRS306 (Sikorski
and Hieter, 1989) to create pLG38. pLG39 was made by religating blunt
ends that were created after removing the internal PflM1/HindIII frag-
ment (codons 369–841) from pLG38, thus creating the 
 
vph1-
 
D
 
369
 
 allele.
The 
 
GAL1-PHO8
 
 construct, pRCP132, was derived from pRCP131.
pRCP131 was made by inserting a BamHI/XbaI PCR fragment encoding
codons 1–567 of 
 
PHO8
 
 (bp 1–1,701) into pTS308 behind the 
 
GAL1
 
 pro-
moter. pTS306 (generously provided by Dr. T. Stearns, Stanford Univer-
sity, Stanford, CA) contains the 
 
GAL1
 
 promoter in a CEN-based 
 
URA3
 
plasmid. pRCP132 was made, creating the 
 
pho8-
 
D
 
329
 
 allele, by destroying
the BglII site of pRCP131 at codon 329 by blunt-end ligation, thus creat-
ing a frame shift mutation and a stop codon at codon 338. 
The 
 
GAL1-PEP4
 
 construct, pRCP39, was made by subcloning a PCR
fragment derived from 
 
PEP4
 
 encompassing codons 1–405 (bp 1–1,413)
into the BamHI/SalI sites of pCJR52, thus placing the 
 
PEP4
 
 gene under
the control of the 
 
GAL1
 
 promoter.
pAIN1, encoding the ALP/DPAP B fusion construct, was made by gen-
erating a PCR fragment containing codons 1–32 of 
 
PHO8
 
 (encoding
ALP) and 29–380 of 
 
DAP2
 
 using an oligonucleotide corresponding to
codons 1–40 of the resulting fusion protein and containing a BamHI site
and an oligonucleotide corresponding to bp 1,140–1,110 of the 
 
DAP2
 
ORF (encoding DPAP B) and containing an SspI site. This PCR product
was digested with BamHI/SspI and ligated to the SspI/HindIII fragment
(bp 599–2,678) from 
 
DAP2
 
 in the BamHI/HindIII of pCJR52 in a three-
part ligation. The pAIN1 construct places the ALP/DPAP B ORF (codons
1–32 of ALP and 29–842 of DPAP B) downstream of the 
 
GAL1
 
 pro-
moter. pAIN2, encoding the 
 
D
 
11 ALP/DPAP B fusion construct, was
made by generating a PCR fragment amplified from pAIN1 that placed a
BamHI site followed by an initiating methionine just before codon 12 of
the ALP/DPAP B ORF using the oligonucleotide: CCGGATCCATGA-
CACGTCTTGTTCC in conjunction with the oligonucleotide: GGAC- 
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GTATGCAATATTATTAG. This PCR product was digested with BamHI/
SspI and ligated to the SspI/HindIII fragment (bp 599–2,678) from 
 
DAP2
 
in the BamHI/HindIII of pCJR52 in a three-part ligation.
pNB3 was derived by deleting codons 2–21 of the 
 
PHO8
 
 ORF from
pSN92 according to the method of Kunkel (Kunkel et al., 1987). pNB4
was similarly derived by deleting codons 2–31 of the 
 
PHO8
 
 ORF from
pSN92. The 
 
vps45
 
D
 
::
 
URA3
 
 construct, pRCP133, was made by inserting a
HindIII fragment containing the 
 
URA3
 
 gene in place of the NheI/Bsu36I
fragment of 
 
VPS45
 
 in pTS34 to create the same deletion as is carried in
the RPY11, RPY12, RPY99, and NBY68 yeast strains (Piper et al., 1994).
pTS34 contains an SmaI/SphI fragment encoding 
 
VPS45
 
 in pRS316 (Piper
et al., 1994). The integrating 
 
vps10-
 
D
 
10
 
* construct, pRCP95, was made by
inserting the SalI/SacI fragment of pTS63 (Cooper and Stevens, 1996) into
pRS305. The SalI/SacI fragment of pTS63 encodes a protein that contains
a STOP codon at codon 1,425 of 
 
VPS10
 
, resulting in a protein that lacks
all but the first 10 amino acids of the COOH-terminal cytosolic tail of
Vps10p.
The 
 
VAM3
 
 gene (bp 
 
2
 
204–1,156) was amplified from genomic DNA
using the PCR and subcloned into the BamHI/EcoRI sites of pRS316 to
generate pCC1. pRCP160 was made by subcloning a PCR fragment en-
coding amino acids 1–264 of Vam3p into the BamHI/EcoRI sites of
pGEX-3X. pRCP161 constitutes the dominant-interfering 
 
VAM3
 
 allele,
 
VAM3-TM
 
D
 
, comprised of the cytosolic domain of Vam3p under the in-
ducible control of the 
 
GAL1
 
 promoter (
 
VAM3-TM
 
D
 
). pRCP161 was
made by subcloning a fragment encoding amino acids 1–264 of Vam3p
into the BamHI/XbaI sites of pCJR52.
 
Strains
 
Strains were constructed using standard genetic techniques and grown in
rich media (1% yeast extract, 1% peptone, 2% dextrose [YPD]) or stan-
dard minimal medium with appropriate supplements. All yeast strains
were derived from the SF838–9D strain (Table II), except for SNY31
which was derived from the sister spore SF838–1D (Nothwehr et al.,
1995). A congenic 
 
PEP4
 
 strain, RPY10, has been described previously
(Piper et al., 1995).
RPY90, RPY94, and RPY111 were derived from RPY15 (
 
vps27-ts
 
),
RPY3 (
 
vps45-ts
 
), and SF838-9D, respectively (Piper et al., 1994, 1995), by
creating the 
 
pho8-
 
D
 
329::LEU2::GAL1-PHO8
 
 and 
 
vph1-
 
D
 
369::URA3::
GAL1-VPH1
 
 loci. To create the 
 
pho8-
 
D
 
329::LEU2::GAL1-PHO8
 
 muta-
tion, pRCP132 (
 
pho8-
 
D
 
369
 
 allele fused to the 
 
GAL1
 
 promoter) was lin-
earized using NcoI and integrated at the 
 
PHO8
 
 locus. This creates a tan-
dem integration where one copy of 
 
PHO8
 
 is under the control of the
 
GAL1
 
 promoter and the other copy of 
 
PHO8
 
 is truncated at codon 329.
To create the 
 
vph1-
 
D
 
369::URA3::GAL1-VPH1
 
 mutation, the plasmid
pLG39 (
 
vph1-
 
D
 
369
 
 allele fused to the 
 
GAL1
 
 promoter) was linearized
with BstEII and integrated at the 
 
VPH1
 
 locus. This creates a tandem inte-
gration where one copy of 
 
VPH1
 
 is under the control of the 
 
GAL1
 
 pro-
moter and the other copy of 
 
VPH1
 
 is truncated at codon 369.
RPY96, RPY110, and RPY103 were derived from RPY10 (wild type),
SF838-9D (
 
pep4-3
 
), and RPY3 (
 
vps27-ts
 
) (Piper et al., 1995), respectively,
by creating the 
 
VPS10::LEU2::vps10-
 
D
 
10
 
* locus. To create the 
 
VPS10::
LEU2::vps10-
 
D
 
10
 
* locus, the plasmid pRCP95 (
 
vps10-D10* allele) was lin-
earized with XbaI and integrated at the VPS10 locus. This creates a tan-
dem integration at the VPS10 locus containing the wild-type VPS10 gene
and the vps10-D10* gene. RPY102 was derived from RPY10 by simulta-
neously transforming with linearized pRCP95 (vps10-D10* construct) and
pRCP56 (vps45-ts construct), followed by selection on 5-fluoroorotic acid
(5-FOA) to excise the endogenous VPS45 gene (Boeke et al., 1984; Piper
et al., 1994). All culture steps for the RPY102 strain were at 228C.
NBY68 was derived from RPY11 (vps45D) by transforming with
pSN111 (pho8-DX construct) linearized with SalI. Ura1 transformants
were plated onto media containing 5-FOA, and pho8-DX colonies were
identified through Western analysis. RPY107 was derived from MY1885
(Piper et al., 1995) by transforming with the HindIII fragment of pCJR18
(dap2D::LEU2 construct). RPY109 was derived from RPY10 by trans-
forming with pLC4-8 followed by selection on 5-FOA at 228C.
RPY95 (vam3D) in which the VAM3 ORF is replaced with the LEU2
gene was made by transforming an ends-out disruption cassette amplified
by PCR into the RPY10 strain. The oligos used were: ATTAACAAA-
TTGGCCAACTAATATCCACTGCAGAAAGTTGAGATTATTTTG-
TACTGAGAGTGCACCAT and GGGCTACCAGAAAGTCTGTG-
CTCAATGCGCGTTTAAGGAGATTAGGTATTTCACACCGCATA
(where the underlined portion represents the region that primes polymer-
ization from the pRS314 plasmid).
Immunofluorescence
Indirect immunofluorescence microscopy for the localization of ALP,
Vph1p, and DPAP B was performed as previously described (Roberts et
al., 1991). Cells were grown in YPD at 308C before fixation unless speci-
fied. For cells harboring plasmids, cells were grown to 1 OD/ml in minimal
media, and then were diluted 1:1 with YPD and allowed to grow for 2 h
before fixation. For experiments involving induction from the GAL1 pro-
moter in temperature-sensitive mutants, cells were grown overnight in
standard minimal media containing 2% raffinose at 228C. Galactose was
 
Table I. Strains Used in This Study 
Strain Genotype Source
RPY10 MATa leu 2-3,112 ura3-52 his4-519 ade6 gal2 Piper et al., 1995
SF838-9D pep4-3 Rothman et al., 1989
HYY1 nps27D::LEU2 pep4-3 Piper et al., 1995
AACY5 nps27D::LEU2 Piper et al., 1995
RPY107 nps27(npl23-5) dap2D::LEU2 This study
RPY11 nps45D Piper et al., 1994
RPY12 nps45D pep4-3 Piper et al., 1994
NBY68 nps45D pho8-DX This study
RPY90 pep4-3 nps27-ts pho8-D329::LEU2::GAL1-PHO8 nph1-D369::URA3::GAL1-VPH1 This study
RPY94 pep4-3 nps45-ts pho8-D329::LEU2::GAL1-PHO8 nph1-D369::URA3::GAL1-VPH1 This study
RPY111* pep4-3 pho8-D329::LEU2::GAL1-PHO8 nph1-D369::URA3::GAL1-VPH1 This study
RPY96 VPS10::LEU2::nps10-10* This study
RPY102 nps45-ts VPS10::LEU2::nps10-10* This study
RPY99 nps45D VPS10::LEU2::nps10-10* Piper et al., 1994
RPY110 pep4-3 VPS10::LEU2::nps10-10* This study
RPY103 pep4-3 vps27-ts VPS10::LEU2::nps10-10* This study
CKRY2-8A pep4-3 nps27D::LEU2 pho8D::LEU2 Raymond et al., 1992
SEY5016 MATa sec1-ts leu2-3,112 ura3-52 Emr et al., 1984
RPY108 MATa nps-45D::URA3 sec1-ts leu2-3,112 ura3-52 This study
JHRY23-10D MATa sec1-1 (ts) nps1-1 (vpl1-1) Rothman and Stevens, 1986
RPY95 MATa vam3D This study
All strains except SEY5016, RPY108, and JHR23-10D are congenic to RPY10.The Journal of Cell Biology, Volume 138, 1997 534
added upon shifting cells to 378C; after 45 min at 378C, cycloheximide was
added to a final concentration of 100 mg/ml 10 min before fixation. Cells
were prepared for immunofluorescence as described previously (Roberts
et al., 1991). Basically, cells were fixed in 3% formaldehyde for 10 min,
followed by incubation in 2% paraformaldehyde/50 mM KPO4, pH 7.0,
for 18 h. Cells were spheroplasted and permeabilized with 1% SDS for 3
min. Cells were washed in 1.2 M sorbitol and allowed to adhere to poly-l-
lysine–coated slides. Incubation of cells with the primary antibody was
performed at 48C overnight followed by 1-h incubations of secondary and
tertiary antibodies at 228C. For experiments requiring labeling of ALP
and Vph1p in the same cells, the anti-ALP 1D3 monoclonal was visualized
using biotinylated secondary antibody in combination with FITC-labeled
streptavidin, and the rabbit anti-Vph1p was visualized using Texas red–
labeled goat anti–rabbit antibody. To localize Vam3p in wild-type and
vps27D cells, cells were transformed with the low copy VAM3 plasmid,
pCC1; however, similar results were obtained with nontransformed cells.
Images were captured on 35-mm film (TMAX-400; Eastman Kodak Co.,
Rochester, NY) with a 3100 Zeiss oil immersion lens on a Zeiss Axioplan
fluorescence microscope (Zeiss, Oberkochen, Germany). Film negatives
were digitized using a Polaroid SprintScan 35 (Polaroid Corp., Cam-
bridge, MA). Images were adjusted with standard settings using Adobe
Photoshop™ (Adobe Systems, Inc., Mountain View, CA).
Pulse/Chase Immunoprecipitations
Secretion of newly synthesized CPY was quantified by immunoprecipita-
tions as previously described (Nothwehr et al., 1995; Piper et al., 1995;
Cooper and Stevens, 1996). Briefly, yeast cultures were grown overnight
in selective synthetic media without methionine to OD600 = 1. Cultures
were adjusted to 50 mM KPO4, pH 5.7, containing 2 mg/ml BSA. 0.5
OD600 cells per time point to be analyzed were labeled for 10 min with 100
mCi 35S-Express label and then chased for specified times by the addition
of excess unlabeled methionine and cysteine (final concentration of 100
mg/ml). The chase was terminated by chilling the cells to 48C in the pres-
ence of 50 mM sodium azide. Cells were separated from the culture media
by centrifugation and then were spheroplasted. CPY was immunoprecipi-
tated from the resulting intracellular (lysed spheroplasts) and extracellu-
lar (media supernatant) fractions and analyzed by SDS-PAGE and fluo-
rography.
For immunoprecipitation of ALP, Vps10p, and related proteins, cells
were prepared and labeled as above but without the addition of BSA or
KPO4 according to previously published procedures (Bryant and Stevens,
1997). After the chase period, cells were spheroplasted and lysed using
1% SDS/8 M urea. Lysates were then adjusted to 0.1% SDS, 0.1% Triton
X-100, 0.8 M urea, and 20 mM Tris, pH 8.0, before the addition of 1 ml
anti-Vps10p or anti-ALP antisera. After a 1.5-h incubation at 48C, Staph
A cells (IgG Sorb) were added for an additional 1.5 h.
Results
Differential Distribution of ALP and Other Vacuolar 
Proteins in vps45D and vps27D Cells
The recent characterization of many VPS genes has en-
abled the development of genetic tools that provide spe-
cific blocks at various stages along the vacuolar biogenesis
pathway from the late Golgi to the vacuole. vps45 muta-
tions appear to block the fusion of a class of Golgi-derived
transport vesicles that are destined to fuse with a PVC
(Cowles et al., 1994; Piper et al., 1994). This block prevents
soluble hydrolases such as CPY and membrane proteins
such as Vph1p (an integral membrane subunit of the vacu-
olar H1-ATPase; Manolson et al., 1992) from reaching the
vacuole (Piper et al., 1994). Mutations in VPS27 cause the
accumulation of an exaggerated form of a PVC (termed
the class E compartment) that traps both Vph1p and CPY
(Raymond et al., 1992; Piper et al., 1995). The effect of
these blocks can be visualized through the localization of
Vph1p in vps45 and vps27 null mutants (Fig. 1 A). Wild-
type (SF838-9D), vps45D (RPY12), and vps27D (HYY1)
cells were grown at 308C, fixed, and decorated with anti-
Vph1p and anti-ALP antibodies. In contrast with its local-
ization in wild-type cells, Vph1p was not found in the vac-
uole in vps45D cells (defined by Nomarski optics as a large
depression). Instead, Vph1p was localized to many small
Table II. Plasmids Used in This Study
Plasmid Description Source
pLG1 GAL1-VPH1 in CEN:URA3 plasmid, pCJR52 This study
pLG39 Integrating GAL1-VPH1 construct: GAL1 promoter fused to nph1-D369 allele in pRS306 This study
pRCP131 GAL1 promoter fused to PHO8 ORF in CEN-URA3 plasmid This study
pRCP132 GAL1-PHO8 integrating plasmid: GAL1 promoter fused to pho8-D329 allele in pRS305 This study
pRCP39 GAL1-PEP4 in CEN-URA3 plasmid This study
pRCP95 nps10-10* LEU2 integrating plasmid (VPS10 without cytosolic tail; STOP codon at amino acid 1,425) This study
pLC4-8 sec4-ts integrating plasmid Nothwehr et al., 1995
pSN92 PHO8 in CEN-URA3 plasmid Nothwehr et al., 1993
pNB3 PHO8 lacking codons 2–21 in CEN-URA3 plasmid This study
pNB4 PHO8 lacking codons 2–31 in CEN-URA3 plasmid This study
pCC1 VAM3 gene in pRS316 This study
pRCP160 GST-VAM3 fusion construct This study
pRCP161 VAM3-TMD allele. GAL1 promoter fused to fragment encoding cytosolic domain of Vam3p
pAIN1 ALP/DPAP B fusion construct: codons 1–31 of PHO8 fused to codons 29–842 of DAP2 behind the GAL1 
promoter in CEN-URA3 plasmid
This study
pAIN2 D11 ALP/DPAP B fusion construct: codons 1, 12–31 of PHO8 fused to codons 29–842 of DAP2 behind the GAL1 
promoter in CEN-URA3 plasmid
This study
pSN100 (F85,F87®A,A) A-ALP in CEN-URA3 plasmid Nothwehr et al., 1993
pCJR6 GAL1-DAP2 construct in CEN:URA3 plasmid Roberts et al., 1989
pRCP56 nps45-ts (nps45-13) integrating plasmid Piper et al., 1994
pKJH2 nps27D::LEU2 disruption plasmid Raymond et al., 1992
pRCP41 nps45D disruption plasmid (loop in/loop out) Piper et al., 1994
pRCP134 nps45D::URA3 disruption plasmid This study
pSN111 pho8-D X disruption plasmid (loop in/loop out) Nothwehr et al., 1995
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punctate structures consistent with its predicted distribu-
tion in the transport vesicles that accumulate in vps45D
mutants (Cowles et al., 1994; Piper et al., 1995). Similarly,
Vph1p was not localized to the vacuole in vps27D cells, but
instead was found within large perivacuolar class E struc-
tures that accumulate when traffic out of the PVC is blocked
(Raymond et al., 1992; Piper et al., 1995). 
Blocks in the vacuolar biogenesis pathway were also ev-
ident in pulse/chase labeling experiments (Fig. 1 B). Newly
synthesized proteins were labeled with [35S]methionine/
cysteine for 10 min, after which CPY was immunoprecipi-
tated from intracellular and extracellular fractions after
various chase times in the presence of unlabeled methio-
nine. Most of the CPY in vps45D cells was secreted and re-
covered in the extracellular fraction. However, the frac-
tion that remained intracellular failed to be converted
from the Golgi-modified p2 form to the mature form, indi-
cating that this intracellular CPY had not been exposed to
proteolytic processing enzymes in the vacuole. These re-
sults agree with previous findings (Cowles et al., 1994;
Piper et al., 1994) and, together with the localization of
Vph1p, suggest that proteins that exit the Golgi in vps45D
cells are trapped within transport vesicles. In vps27D cells,
the block at the prevacuolar compartment was not evident
by following the processing of newly synthesized CPY
since the intracellular CPY was processed to the mature
form in these cells. However, previous studies have shown
that this is not indicative of CPY reaching the vacuole
since the class E prevacuolar compartment is proteolyti-
cally active (Raymond et al., 1992; Piper et al., 1994; Bry-
ant and Stevens, 1997) and CPY can be immunolocalized
to the class E compartment (Raymond et al., 1992).
In contrast with the nonvacuolar localization of Vph1p
in vps45D and vps27D cells, another membrane protein,
ALP, was found exclusively in the vacuole (Fig. 1 A).
These results are consistent with previous studies (Ray-
mond et al., 1992; Piper et al., 1994). Not only was the dif-
ferential localization of ALP and the vacuolar protein
Vph1p observed by immunofluorescence localization stud-
ies, but ALP also appeared to be targeted differently when
analyzed by pulse/chase analysis. ALP, the product of the
PHO8 gene, is a type II membrane protein that undergoes
a  PEP4-dependent cleavage upon reaching the vacuole
(Kaneko et al., 1987; Klionsky and Emr, 1989). This pro-
cessing event serves as a convenient way to monitor the
trafficking of ALP to vacuolar membranes (Klionsky and
Emr, 1989). Fig. 1 B shows that, despite the block of intra-
cellular CPY processing in vps45D cells, ALP was fully
processed with nearly wild-type kinetics into its mature
forms (Bryant and Stevens, 1997). In vps27D cells, ALP
was also processed, although in this case the localization of
ALP to the vacuole can only be inferred from the immu-
nolocalization data since the class E prevacuolar compart-
ment is proteolytically active.
Trafficking of ALP and Other Membrane Proteins
to the Vacuole Is Independent of Vps45p-dependent 
Transport Vesicles and the Vps27p-dependent 
Prevacuolar Compartment
The data presented thus far indicate that, despite the pro-
found blocks in the vacuolar biogenesis pathway that
vps45 and vps27 mutations impose, ALP is still localized to
the vacuole. One model is that ALP departs the yeast
Golgi via a different route than that taken by proteins such
as Vph1p and the CPY/CPY receptor (Vps10p) complex.
Thus, membrane proteins such as Vph1p as well as vacu-
olar proteases would reach the vacuole via a VPS-depen-
dent pathway, whereas ALP would reach the vacuole via
an alternative bypass pathway. While the data in Fig. 1 are
consistent with this interpretation, the immunofluores-
cence experiments examined only the steady state distri-
bution of ALP and Vph1p in vps27 and vps45 mutant cells,
which may not accurately reflect any kinetic effects on
newly synthesized proteins. The pulse/chase analyses also
may be difficult to interpret strictly since ALP is compared
to a soluble vacuolar hydrolase, CPY, which may well have
a different set of requirements for reaching the vacuole
and becoming proteolytically processed since it is a soluble
protein that is carried through part of the vacuolar biogen-
esis pathway by a recycling membrane protein receptor
Figure 1. Differential localization of ALP and other vacuolar
proteins. (A) Double label immunofluorescence of Vph1p (upper
panels) and ALP (middle panels) is shown for wild-type cells
(SF838-9D), vps45D cells (RPY12), and vps27D cells (HYY1).
The depressions visible in the Nomarski image (lower panels)
identify the yeast vacuole. (B) Immunoprecipitation of newly
synthesized ALP and the soluble vacuolar hydrolase CPY in
wild-type cells (RPY10), vps45D cells (RPY11), and vps27D cells
(AACY5). Newly synthesized proteins were labeled for 10 min at
308C with the addition of 35S-Express. Excess unlabeled methio-
nine and cysteine were then added for the indicated times. After
centrifugation, internal (pellet) and external (supernatant) frac-
tions were then prepared. CPY was immunoprecipitated from in-
tracellular and extracellular fractions and ALP was immunopre-
cipitated from intracellular fractions. The PEP4-dependent cleavage
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(Marcusson et al., 1994). Finally, this analysis was per-
formed in cells carrying null mutations that not only result
in the depletion of the processing enzymes resulting in a
Pep2 phenotype (Jones, 1990), but also may lead to indi-
rect effects and to induce cryptic trafficking pathways as
has been observed with chc1D cells and other mutations
(Seeger and Payne, 1992b; Nothwehr et al., 1995).
To address these concerns, we used cells carrying tem-
perature-sensitive alleles of either VPS45 or VPS27 that
rapidly lose their function in cells shifted from 228C to
378C. This strategy ensured that the vacuolar biogenesis
pathway(s) suffered no long-term defects and that vacu-
olar morphology and function were normal. We then fol-
lowed a wave of newly synthesized ALP and Vph1p using
immunofluorescence localization in cells that had under-
gone rapid inactivation of Vps45p or Vps27p function
(Fig. 2). For these experiments, the VPH1 and PHO8
(ALP) open reading frames were placed under the control
of the inducible GAL1 promoter. This was accomplished
by creating a tandem integration at both the VPH1 and
PHO8 loci, which truncated the endogenous copy of the
gene while inserting a new copy of the gene containing
the GAL1 promoter. Within 40 min of adding galactose,
the level of induced protein was sufficient to follow newly
synthesized protein by immunofluorescence localization
as shown in Fig. 2 (bottom) where ALP and Vph1p label-
ing were only discernible in cells induced by galactose.
A 45-min wave of newly synthesized protein was in-
duced from the GAL1 promoter in vps27-ts or vps45-ts
cells that were maintained either at 228C or raised to 378C
concomitant with galactose addition. Fig. 2 shows that at
378C Vph1p did not reach the vacuole in vps45-ts cells
(RPY94), but instead was found in many punctate struc-
tures similar to its distribution in vps45D cells and consis-
tent with its distribution in transport vesicles. In these
same cells, however, newly synthesized ALP was only
found in the vacuole. In three experiments, examination of
.300 double-labeled cells that showed the vesicular distri-
bution of Vph1p showed that ALP was vacuolar, and no
ALP could be detected in vesicular-like structures.
Similar experiments were performed on vps27-ts cells
(RPY90). Previous studies have shown that the character-
istic morphology of the class E prevacuolar compartment
forms well within 15–20 min after raising vps27-ts cells to
the nonpermissive temperature (Piper et al., 1995; Bryant
and Stevens, 1997). At 378C, newly synthesized Vph1p was
found in class E prevacuolar compartments and did not
reach the vacuole. While Vph1p had been trapped in the
rapidly formed class E compartment, newly synthesized
ALP was found in the vacuole. In four experiments, .400
double-labeled cells that showed Vph1p within the class E
prevacuolar compartment were examined; all showed ALP
within the vacuole as outlined by Nomarski optics. No
ALP was observed colocalized with Vph1p in class E pre-
vacuolar structures.
To show that the vacuolar biogenesis pathway was fully
functional before the temperature shift, the synthesis of
ALP and Vph1p was induced at 228C in both vps45-ts and
vps27-ts cells. Fig. 2 shows that both ALP and Vph1p
reach the vacuole as in wild-type cells (data not shown).
To show that the differential temperature-sensitive effects
on the sorting of ALP and Vph1p were solely due to the
vps27-ts or vps45-ts alleles, wild-type cells carrying the
GAL1-VPH1 and GAL1-ALP alleles (RPY111) were ex-
amined and found to deliver efficiently both proteins to
the vacuole at 378C (Fig. 2).
Figure 2. Differential targeting of ALP and Vph1p in tempera-
ture-sensitive vps mutants. The targeting of newly synthesized
Vph1p and ALP was monitored in vps45-ts cells (RPY94; top
panels),  vps27-ts cells (RPY90; middle panels), and wild-type cells
(RPY111;  bottom panels). The production of both ALP and
Vph1p in RPY94, RPY90, and RPY111 cells was under the con-
trol of the galactose-inducible GAL1 promoter. Cells were grown
overnight at 22°C in the absence of galactose. Galactose was then
added, and cells were incubated for 45 min at 228C or immedi-
ately shifted to 378C as indicated. Cycloheximide was then added
(100 mg/ml) for an additional 10 min before fixation and double
labeled for Vph1p and ALP using indirect immunofluorescence.
Vph1p was labeled with rabbit anti-Vph1p antibodies and Texas
red–conjugated secondary antibody (left panels); ALP was la-
beled with anti-ALP 1D3 mAb with biotinylated secondary and
FITC-conjugated streptavidin. Shown as a control are wild-type
cells (RPY111) incubated at 378C in the presence or absence of
galactose (lower panels).Piper et al. A Newly Identified Route to the Yeast Vacuole 537
PEP4-dependent Processing of ALP But Not
Another Vacuolar Membrane Protein, Vps10p-D10*, 
Occurs Despite Blocks in the
VPS-dependent Pathway
We also used a pulse/chase analysis to assess the transport
route of newly synthesized membrane proteins to the vac-
uole. In order to compare ALP with another membrane
protein that undergoes a PEP4-dependent processing, we
chose to follow the fate of the vacuolar protein Vps10p-
D10*. The Vps10-D10* protein is a mutant form of the
CPY receptor, Vps10p, which lacks all but 10 amino acids
of its COOH-terminal cytosolic tail (Cooper and Stevens,
1996). Several features make this a useful membrane pro-
tein marker to monitor the function of the vacuolar bio-
genesis pathway: firstly, all of the known information in
the cytosolic tail that localizes Vps10p to the Golgi has
been eliminated, resulting in a protein that is localized to
the vacuole with rapid kinetics (Cooper and Stevens,
1996); secondly, it undergoes a PEP4-dependent cleavage
upon reaching the vacuole (Cereghino et al., 1995; Cooper
and Stevens, 1996); finally, the Vps10-D10* protein local-
izes to the class E prevacuolar compartment in vps27D
cells, indicating that it reaches the vacuole via the VPS-
dependent pathway (Cooper, A.A., and T.H. Stevens, un-
published observations).
In wild-type cells (RPY96) Vps10p-D10* is rapidly pro-
cessed with a half-time of z20 min, consistent with previ-
ous measurements (Cooper and Stevens, 1996; Bryant and
Stevens, 1997). The full-length Vps10 protein was also fol-
lowed in these cells to serve as a convenient internal con-
trol. In wild-type cells Vps10p is quite stable, owing to ty-
rosine-based signals within its cytosolic domain that confer
its retrieval to the Golgi apparatus and prevent its delivery
to the vacuole (Cereghino et al., 1995; Cooper and Stevens,
1996) (Fig. 3). In vps45D cells, Vps10p-D10* failed to un-
dergo a PEP4-dependent cleavage (Fig. 3 A), consistent
with its being trapped in transport vesicles and thus pre-
vented from reaching the vacuole. These data demonstrate
that Vps10p-D10* can be used to monitor blocks along the
VPS-dependent pathway.
Using the cleavable membrane protein Vps10p-D10* as
a reporter, we examined the trafficking of ALP to the vac-
uole in cells that had sustained recent and abrupt blocks in
the VPS-dependent pathway. In vps45-ts cells at 228C, the
delivery of ALP and Vps10p-D10* to the vacuole showed
the same kinetics as that observed in wild-type cells (Fig.
3 B). However, in vps45-ts cells shifted to 378C for 10
Figure 3. Trafficking of
ALP and Vps10p-D10* in
temperature-sensitive  vps
mutants. (A) The rate of
PEP4-dependent processing
of Vps10p-10* (left panels)
and ALP (right panels) was
measured in wild-type cells
(RPY96) and vps45D cells
(RPY99) by pulse/chase
analysis. Cells were labeled
with 35S-Express for 10 min
at 308C and chased for the in-
dicated times. Cell lysates
were divided and subjected
to immunoprecipitation with
anti-ALP and anti-Vps10p
antibodies. Both the full-
length Vps10p and the trun-
cated Vps10p-D10* were
present. The PEP4-depen-
dent cleavage products of
Vps10p-D10* and ALP are
indicated (*). (B) The rate of
PEP4-dependent cleavage
of Vps10p-D10* and ALP
was measured in vps45-ts
cells (RPY102). Cells were
grown overnight at 228C and
then either maintained at
228C or shifted to 378C 10
min before labeling with 35S-
Express for 10 min. The
chase times used are indi-
cated. ALP and Vps10p-
D10* were immunoprecipi-
tated as described above. The rate of PEP4-dependent cleavage of Vps10p-D10* and ALP was measured in vps27-ts cells (RPY103) and
wild-type cells (RPY110) each carrying the GAL1-PEP4 plasmid, pRCP39. Cells were grown in galactose-containing media for 24 h at
228C and then shifted to glucose-containing media for 24 h before the pulse/chase immunoprecipitation scheme used for vps45-ts cells
(RPY102) above. Cells were either maintained at 228C or shifted to 378C 10 min before labeling.The Journal of Cell Biology, Volume 138, 1997 538
min before labeling, Vps10p-D10* did not undergo PEP4-
dependent cleavage, indicating that it was blocked in a
compartment preceding the vacuole. In contrast, ALP in
these cells was rapidly processed, indicating that despite
the profound block in membrane traffic imposed by the
vps45-ts allele, ALP was faithfully delivered to the vacuole.
To perform a similar analysis in vps27-ts cells, measures
were taken to prevent the newly formed class E prevacu-
olar compartment from becoming proteolytically active as
is typically observed (Piper et al., 1995). This was to allow
proteins caught in the class E compartment to be distin-
guished from those delivered to the vacuole by following
their PEP4-dependent cleavage. To accomplish this, wild-
type and vps27-ts cells carried a plasmid in which the
PEP4 open reading frame was placed under the control of
the inducible GAL1 promoter (pRCP39). Cells grown in
media containing galactose would be Pep1; however, when
cells are shifted to glucose to shut off production of Pep4p,
active vacuolar proteases would be flushed from PVCs,
thus allowing the newly formed class E prevacuolar com-
partment to remain incapable of PEP4-dependent pro-
cessing. Under this strategy, the vacuole itself would re-
main proteolytically active as a result of the phenomenon
of phenotypic lag, in which the autocatalytic activation cy-
cle of protease B results in this and other proteases re-
maining active for many cell divisions after elimination of
Pep4p (Zubenko et al., 1982; Jones, 1991). Western analy-
sis of wild-type cells transformed with pRCP39 grown on
glucose demonstrated no PEP4-dependent processing of
CPY or ALP. However, in cells grown in galactose, or in
cells shifted from galactose to glucose for 24 h, all of the
ALP and CPY was found in the processed form (data not
shown), indicating that the GAL1-PEP4 plasmid could be
used to exert tight control over PEP4 expression.
To monitor the delivery of ALP and Vps10p-D10* to the
vacuole in cells lacking Vps27p function, vps27-ts GAL1-
PEP4 cells were grown at 228C in media containing 2%
raffinose and 2% galactose for 24 h, after which cells were
diluted in media containing 2% glucose and grown at 228C
for an additional 24 h. Cells were then shifted to 228C or
378C for 10 min and subjected to pulse/chase analysis to
follow the fate of both newly synthesized ALP and newly
synthesized Vps10p-D10* as described above. Fig. 3 B
shows that at 228C both ALP and Vps10p-D10* were
cleaved with normal kinetics, indicating that both had
reached the vacuole. These data show that, as expected,
the vacuole in these cells is fully capable of processing
both ALP and Vps10p-D10* despite the fact that there had
been no Pep4p production for several generations. At
378C, the VPS-dependent pathway was blocked as demon-
strated by the severe inhibition of Vps10p-D10* process-
ing. These data indicate that Vps10p-D10* was trapped
within a proteolytically inactive form of the class E prevac-
uolar compartment unable to reach the vacuole. In con-
trast, ALP within the same cells was processed with the
same kinetics as that observed in wild-type cells. To fur-
ther demonstrate the efficacy of the GAL1-PEP4 tech-
nique, wild-type cells carrying the GAL1-PEP4 plasmid
were also analyzed. The processing of ALP and Vps10p-
D10* was rapid at both 378C and 228C (Fig. 3); this rate
was indistinguishable from wild-type cells carrying the
wild-type  PEP4 gene (data not shown).
ALP Is Transported to the Vacuole by an
Intracellular Route and Does Not Transit through the 
Plasma Membrane
These results strongly support a model in which ALP is
delivered to the vacuole from the Golgi by a route that by-
passes VPS45-dependent Golgi-derived transport vesicles
and the VPS27-controlled PVC. One other well-described
route to the vacuole is for proteins to transit through the
plasma membrane before being endocytosed to the vacu-
ole. This route via the cell surface is taken by the Ste3p,
Ste2p, and Ste6p membrane proteins, and their delivery to
the vacuole requires function of the late secretory pathway
(i.e., Sec4p) and the endocytic pathway (i.e., End4p)
(Berkower et al., 1994; Nothwehr et al., 1995). ALP does
not follow this route in wild-type cells since the delivery of
ALP to the vacuole is independent of Sec4p function and
End4p function, which are required for secretory vesicle
fusion and endocytosis from the plasma membrane, re-
spectively (Novick et al., 1981; Raths et al., 1993). It is also
unlikely that such a route is induced by mutations in
VPS27 since if ALP was transported to the vacuole via en-
docytosis it would likely become trapped in the Vps27p-
controlled class E PVC (Piper et al., 1995). Thus, ALP
likely takes an alternative intracellular route to the vacu-
ole, perhaps entering a new class of Golgi-derived vesicles.
The above studies do not exclude the formal possibility
that loss of Vps45p function induces a novel pathway for
ALP to the vacuole via the cell surface. This activation of a
cell surface cryptic pathway has been observed with vps1
mutant cells, where Golgi proteins and vacuolar proteins
including ALP are delivered to the vacuole only after be-
ing diverted to the cell surface (Nothwehr et al., 1995).
This effect is understandable since Vps1p is predicted to
act in vesicle formation in the late Golgi apparatus and
would be required to segregate and sort proteins away
from the secretory system (Wilsbach and Payne, 1993;
Conibear and Stevens, 1995). In contrast, the proposed
role of Vps45p is to effect vesicle fusion based on its mu-
tant phenotype and the fact that it is a Sec1p-like homo-
logue (Aalto et al., 1992). Thus, it is unlikely that loss of
Vps45p function would modify traffic out of the Golgi, es-
pecially given the data in Figs. 2 and 3 B, where a rapid on-
set of temperature-sensitive alleles of VPS45 was used. To
eliminate this possibility, we confirmed that the trafficking
of ALP to the vacuole in vps45D cells was also indepen-
dent of the late secretory pathway. Fig. 4 shows that ALP
was processed with normal kinetics in sec1-ts cells at 378C
in the presence or absence of VPS45. Immunoprecipita-
tion of CPY from intracellular and extracellular fractions
of the same cells showed that secretion was blocked by the
sec1-ts allele at 378C. In contrast with the ability of ALP to
route intracellularly to the vacuole in the absence of
Vps45p function, we found that cells without Vps1p func-
tion cannot deliver ALP to the vacuole without Sec1p
function as observed in previous studies (Nothwehr et al.,
1995). Together these data support the view that ALP is
not rerouted to the cell surface by vps45D mutations.
Rather, ALP travels from the Golgi apparatus to the vacu-
ole via an alternative intracellular route that bypasses both
the Vps45p-controlled transport vesicle step and the
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ALP Transport to the Vacuole Is Dependent on the 
Vacuolar Syntaxin Vam3p
The above studies show that the VPS-dependent pathway
defined by the functions of VPS45 and VPS27 is responsi-
ble for delivery of a subset of membrane proteins exclud-
ing ALP to the vacuole. One model is that ALP is sorted
into a separate class of vesicles at the TGN that later fuse
with the vacuole and bypass the prevacuolar compart-
ment. While the specific blocks imposed by the vps45-ts
and vps27-ts alleles demonstrate that ALP transport by-
passes the prevacuolar compartment, we sought to charac-
terize further the alternative pathway by identifying ma-
chinery that controls the delivery of ALP to the vacuole.
One such candidate was the syntaxin family member,
Vam3p. Vam3p has been localized to the yeast vacuole
and plays a role in the homotypic fusion of vacuoles
(Nichols et al., 1997), and vam3 mutants were originally
isolated in a screen for yeast with abnormal vacuolar mor-
phology (Wada et al., 1992). As a proposed vacuolar syn-
taxin, we reasoned that Vam3p might also catalyze other
fusion events with the vacuole, allowing proteins from the
VPS-dependent pathway and/or the alternative pathway
to be delivered to the vacuole. We also reasoned that any
proteins that catalyzed the fusion of ALP-containing vesi-
cles with the vacuole would themselves have to be deliv-
ered to the vacuole in a manner independent of the VPS-
dependent pathway. Fig. 5 shows that Vam3p fits these
criteria. Consistent with the results of Nichols et al. (1997),
we found Vam3p was localized to the vacuole in wild-type
cells (data not shown), and, interestingly, we also found
that Vam3p was localized to the vacuole in vps27D cells,
suggesting that Vam3p itself follows the alternative path-
way to the vacuole.
Null mutants of VAM3 display fragmented vacuoles typ-
ical of class B vps mutants (Wada et al., 1992). Pulse/chase
analysis shows that in vam3D mutants both ALP and the
VPS-dependent pathway marker protein, Vps10p-D10*,
were not processed (Fig. 5). These data indicated that
Vam3p function is required for delivery of proteins from
both the VPS-dependent pathway and the alternative
pathway. Such a dual function for Vam3p would be consis-
tent with the recent finding that Vam3p is also required
for vacuolar homotypic fusion (Nichols et al., 1997). The
block in both ALP processing and the processing of
Vps10p-D10* was also evident in other class B vps mutants
including the ypt7 ( YPT7 encodes a rab7 homologue),
vam7 (VAM7 encodes a protein bearing homology with
SNAP-25), and the class C vps mutant, vps33 (VPS33 en-
codes a Sec1p-like protein). The common phenotypes dis-
played by these mutants suggest that the molecules they
represent all constitute part of the fusion machinery that
allows the delivery of proteins by both the VPS-dependent
and the alternative pathways.
To test this possibility we constructed a conditional al-
lele of VAM3. As a syntaxin homologue, the cytosolic do-
main of Vam3p would be predicted to bind a host of other
proteins (e.g., v-SNARE, Sec17p, and a Sec1p-like pro-
tein) to fulfill its function. Overexpression of the cytosolic
tail of Vam3p might compete with the wild-type Vam3p
and thus exert a dominant-interfering effect. Thus, we
placed a fragment encoding the entire Vam3p cytosolic
domain (VAM3-TMD) behind the inducible GAL1 pro-
moter and monitored the effects of expression at various
times after induction with galactose. Production of the cy-
tosolic domain of Vam3p resulted in a block in the pro-
cessing of both ALP and Vps10p-D10*. This processing
delay was apparent after 15 min of induction with galac-
tose and was more pronounced after 30 min of induction
with galactose. Production of the Vam3p cytosolic domain
was also monitored in the pulse/chase analysis and showed
that high levels of synthesis were achieved by 30 min of ga-
lactose treatment (data not shown).
ALP Contains Information in its Cytosolic Tail That 
Targets It to the Alternative Bypass Pathway
With the exception of ALP and Vam3p, all of the vacuolar
membrane proteins thus far examined travel to the vacu-
Figure 4. ALP does not
travel to the cell surface in
vps45D cells. The rate of
PEP4-dependent cleavage
of ALP was measured in
wild-type cells (RPY96),
sec1-ts cells (RPY109), sec1-
ts  vps45D cells (YM), and
sec1-ts vps1D cells (SNY31).
Cells were grown overnight
at 228C and either main-
tained at 228C or shifted to
378C for 15 min before label-
ing for 10 min with 35S-
Express. Label was chased
for the indicated times. After
centrifugation, internal (pel-
let) and external (superna-
tant) fractions were pre-
pared, divided, and subjected
to immunoprecipitation with
anti-CPY and anti-ALP anti-
bodies.The Journal of Cell Biology, Volume 138, 1997 540
ole by the VPS-dependent pathway. This includes not only
proteins such as Vph1p and DPAP B, which function as
vacuolar proteins, but also proteins that lack specific tar-
geting information such as the Vps10p-D10* and other late
Golgi proteins with mutations in their cytosolic tail, Golgi
localization determinants (Nothwehr et al., 1993; Cooper
and Stevens, 1996; Bryant and Stevens, 1997). Thus, at the
outset, it seemed plausible that there would be a positive
acting signal within the ALP protein responsible for its
sorting into the alternative bypass pathway.
Previous analyses in vps27D cells showed that replace-
ment of the cytosolic NH2-terminal region of ALP with
that of a Golgi-localized membrane protein, Ste13p, as
well as mutant cytosolic tails of Ste13p, resulted in a pro-
tein that is localized to the class E compartment (Ray-
mond et al., 1992; Bryant and Stevens, 1997). Therefore,
we reasoned that at least part of the sorting information
was within the cytosolic tail of ALP. To test this theory, we
analyzed the targeting of mutant ALP proteins bearing de-
letions of the first 21 and 31 amino acids (ALP D2–21,
ALP D2–31). We assessed whether these proteins would
localize to the vacuole or instead would be found within
the class E prevacuolar compartment in vps27D cells,
which would indicate whether these proteins had entered
the  VPS-dependent pathway. To complement this ap-
proach, we used pulse/chase immunoprecipitation analysis
to determine whether these proteins were susceptible to
the block in membrane traffic in vps45D cells or, like the
full-length ALP, whether they still contained the informa-
tion necessary to bypass this block. Fig. 6 shows that both
the ALP and the ALP D2–21 protein are delivered to the
vacuole in vps27D cells and vps45D cells. Both proteins
were found exclusively in the vacuole by immunofluores-
cence in vps27D cells, and both proteins were processed in
vps45D cells with the same kinetics as that observed in
wild-type cells. However, the ALP D2–31 protein, which
lacks the first 31 amino acids of the ALP cytosolic domain
(a truncation resulting in a cytosolic tail of about three
amino acids), was localized to the class E prevacuolar
compartment as shown by immunofluorescence localiza-
tion. As a control, we also analyzed the targeting of an
Ste13/ALP fusion protein derivative designated (F/A)
A-ALP, which follows the VPS-dependent pathway to the
vacuole. This protein consists of the transmembrane and
luminal domains of ALP fused to the cytosolic tail of the
Golgi protein Ste13p, in which the Golgi retrieval target-
ing motif FXFXD has been ablated (Nothwehr et al.,
1993). In wild-type cells the (F/A) A-ALP protein is local-
ized to the vacuole, and in vps27D cells it is localized to the
class E prevacuolar compartment (Bryant and Stevens,
1997).
Consistent with these results, the PEP4-dependent pro-
cessing of ALP D2–31 was blocked in vps45D cells, indicat-
ing that this protein had lost information necessary for en-
try into the alternative bypass pathway (Fig. 6). As
predicted, processing of the (F/A) A-ALP protein was
also blocked in vps45D cells, while both the ALP and the
ALP D2–21 protein were processed with kinetics similar to
that observed in wild-type cells. In wild-type cells, all
ALP-based proteins were correctly targeted to the vacuole
as shown by immunofluorescence (data not shown) and
pulse/chase immunoprecipitation analysis (Fig. 6). These
data show that the amino acids near the transmembrane
domain of the cytosolic tail are necessary for entry of ALP
into the alternative pathway.
To determine whether the cytosolic domain of ALP
contained sufficient sorting information for the alternative
pathway, we analyzed a chimeric protein composed of the
cytosolic domain of ALP fused to the transmembrane and
luminal domains of another type II membrane protein,
Figure 5. The vacuolar syntaxin Vam3p is required for the alter-
native bypass pathway. (A) Localization of Vam3p in vps27D
cells. Vam3p was labeled with rabbit anti-Vam3p antibodies, bi-
otinylated secondary and FITC-conjugated streptavidin (middle
panels). As a marker of the class E prevacuolar compartment, the
60-kD subunit of the vacuolar ATPase, Vma2p, was localized
with the mAb 13D11B2 and Texas red–conjugated secondary an-
tibody (left panels). (B) The rate of PEP4-dependent processing
of Vps10p-10* (left panels) and ALP (right panels) was measured
in vam3D cells (RPY95). Cells were labeled with 35S-Express for
10 min at 308C and chased for the indicated times. Cell lysates
were divided and subjected to immunoprecipitation with anti-ALP
and anti-Vps10p antibodies. (C) The rate of PEP4-dependent
processing of Vps10p-10* (left panels) and ALP (right panels)
was measured in wild-type cells (RPY96) carrying the dominant-
interfering allele VAM3-TMD (pRCP161) under the inducible
control of the GAL1 promoter. pRCP161 expresses the cytosolic
domain of Vam3p in response to the addition of galactose. Cells
were grown overnight at 308C in raffinose. Galactose was then
added for the indicated times (no addition, 15 min, or 30 min) be-
fore labeling cells with 35S-Express for 10 min at 308C. Label was
chased for the indicated times and cell lysates were divided and
subjected to immunoprecipitation with anti-ALP and anti-Vps10p
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DPAP B (Roberts et al., 1989). To assay the targeting of
these proteins, the ALP/DPAP B chimera and DPAP B
were expressed using the GAL1 promoter and immunolo-
calized in vps27D cells. DPAP B was found in class E–like
prevacuolar structures, indicating that DPAP B traveled
through the VPS-dependent pathway since it was unable
to bypass the vps27D-imposed block (Fig. 7). Approximately
94% of labeled cells examined showed labeling of DPAP
B exclusively in class E prevacuolar structures. In contrast,
the ALP/DPAP B chimera was found exclusively in the
vacuole in vps27D cells. The ALP/DPAP B chimera was
not detected in class E prevacuolar structures in .400 cells
examined. Deletion of the NH2-terminal amino acids 2–11
of the ALP/DPAP B chimera did not affect its targeting
to the vacuole, consistent with the deletion analysis in Fig.
6. Together these data show that the cytosolic tail of ALP
contains information in the sequence RPKKRRISKRSK
adjacent to the transmembrane domain that constitutes
the sorting domain for targeting into the alternative by-
pass pathway.
Discussion
Two Intracellular Pathways for Yeast Vacuolar 
Membrane Proteins
Proteins that enter the secretory pathway transit through
the ER and successive Golgi compartments. Although this
process has now been recognized as selective at each vesi-
cle transport stage, all anterograde traffic appears to travel
through the same pathway (Pelham and Munro, 1993;
Rothman and Wieland, 1996; Schekman and Orci, 1996).
Once proteins enter the TGN they face a very complex de-
cision. In mammalian cells, proteins can leave the TGN in
one of many vesicles including basolaterally or apically
targeted secretory vesicles bound for the plasma mem-
brane, regulated secretory granules, or clathrin-coated
vesicles that transport them to endosomal/lysosomal com-
partments (Bauerfeind et al., 1994; Jahn and Sudhof, 1994;
Robinson, 1994; Ikonen et al., 1995; Hunziker and Geuze,
1996). This level of complexity is also seen in other eu-
karyotic cells such as Saccharomyces cerevisiae. The “yeast
TGN” can be defined as the last functional compartment
of the Golgi (Graham and Emr, 1991; Redding et al.,
1991). Proteins that enter the yeast TGN can depart either
by being retrieved to earlier compartments (Harris and
Waters, 1996), by entering vesicles bound for a PVC sub-
sequently allowing proteins to reach the vacuole (Coni-
bear and Stevens, 1995; Horazdovsky et al., 1995), or by
Figure 6. The cytosolic domain of ALP is necessary for entry into
the alternative bypass pathway. (A) Schematic description of the
ALP mutant proteins analyzed. Truncations in the NH2-terminal
cytosolic tail of ALP were made by deleting the first 21 or 31
codons of the ALP open reading frame to generate pNB3 (D2–21
ALP) and pNB4 (D2–31 ALP). The (F/A) A-ALP protein con-
sists of the luminal and transmembrane domains of ALP fused to
the cytosolic tail of Ste13p in which the Golgi localization motif
FXFXD has been ablated by the mutation AXAXD. (B) The dis-
tribution of the mutant ALP proteins (wild-type ALP, D2–21,
D2–31, and [F/A] A-ALP) was assessed in vps27D pho8 cells
(CKRY2-8A) transformed with CEN-URA3 plasmids, pSN92
(ALP), pNB3 (D2–21-ALP), pNB4 (D2–31-ALP), and pSN100
([F/A] A-ALP) using immunofluorescence. Transformants were
fixed and labeled with anti-ALP antibodies together with biotiny-
lated secondary antibodies and FITC-conjugated streptavidin.
(C) The PEP4-dependent cleavage of the mutant ALP proteins
(wild-type ALP, D2–21, D2–31, and [F/A] A-ALP) was assessed
in vps45D pho8D cells (NBY68) using pulse/chase analysis. Trans-
formants were labeled for 10 min with 35S-Express and chased for
the indicated times, after which time lysates were subjected to im-
munoprecipitation with anti-ALP antibodies. (D) Schematic rep-
resentation of the cytosolic tail of ALP. (Arrowheads) Second
residue (after methionine) of the deletion constructs.
Figure 7. The cytosolic domain of ALP can confer sorting into
the alternative bypass pathway. The schematic (right) shows the
wild-type DPAP B protein (DPAP B), a chimeric protein com-
prised of the cytosolic domain of ALP fused to the transmem-
brane and luminal domains of DPAP B (ALP/DPAP B), and an
ALP/DPAP B chimeric protein with a deletion of amino acids
2–11 of the ALP cytosolic domain. All constructs (pCJR6, pAIN1,
and pAIN2, respectively) were under the control of the GAL1
promoter. The targeting of these proteins was analyzed by immu-
nofluorescence (left) in vps27 dap2D cells (RPY107) transformed
with pCJR6 or pAIN1. Transformants were grown overnight in
raffinose, shifted to 2% galactose for 1 h, fixed, and then pro-
cessed for immunofluorescence labeling using anti–DPAP B anti-
bodies, biotinylated secondary antibody, and FITC-conjugated
streptavidin.The Journal of Cell Biology, Volume 138, 1997 542
entering one of two vesicle populations that will ultimately
deliver cargo to the plasma membrane (Govidan et al.,
1995; Harsay and Bretscher, 1995). The experiments re-
ported here underscore the complexity of protein sorting
at the yeast TGN by establishing an additional pathway
from the Golgi to the vacuole that is distinct from the es-
tablished vacuolar biogenesis pathway defined by various
VPS gene functions.
A current model for how CPY is delivered to the vacuole
along the vacuolar biogenesis pathway has been proposed
previously (Conibear and Stevens, 1995; Horazdovsky et
al., 1995) and is presented in Fig. 8. Membrane proteins
depart the Golgi by entering transport vesicles that fuse
with a PVC. From this compartment, proteins can either
recycle back to the Golgi, as is the case for the TGN pro-
teins Ste13p and Vps10p, or travel on to the vacuole, as
is the route taken by the vacuolar H1-ATPase subunit,
Vph1p. Although this model is largely based on work in
mammalian cells that examines the trafficking of the man-
nose-6-phosphate receptor, direct evidence for this model
comes from fractionation experiments that purified PVCs
(Vida et al., 1993) as well as from work that has used spe-
cific mutant alleles in certain VPS genes to accumulate
membrane trafficking intermediates (Raymond et al., 1992;
Piper et al., 1995).
In this study we have used both vps45-ts and vps27-ts
mutations to impose specific blocks along the vacuolar
biogenesis pathway. Loss of Vps45p function prevented
newly synthesized Vph1p and Vps10p-D10* from reaching
the vacuole, and Vph1p was found within small vesicular
structures, consistent with its being trapped within trans-
port vesicles that are observed by EM (Cowles et al., 1994;
Piper et al., 1994). Loss of Vps27p function also resulted in
blocking Vph1p and Vps10p-D10* from reaching the vacu-
ole. In this case, newly synthesized Vph1p was found in a
characteristic class E compartment that previous studies
have demonstrated to represent an exaggerated form of
the PVC (Raymond et al., 1992; Piper et al., 1995; Rieder
et al., 1996). Despite the rapid and profound blocks im-
posed by loss of Vps45p and Vps27p function, the vacuolar
protein ALP was able to reach the vacuole. These data not
only suggest that ALP leaves the Golgi via a different
route than the Golgi-derived transport vesicles that carry
Vph1p and Vps10p, but also that ALP is not delivered to
the PVC. Our model proposes that ALP is carried directly
to the vacuole; however, a series of yet unknown traffick-
ing intermediates may well be involved. Although exactly
which membrane intermediate(s) is involved in ALP’s
transit to the vacuole remains unclear, the simplest hy-
pothesis is that ALP enters a different set of transport ves-
icles that are distinct from those of the VPS-dependent
pathway or those destined for the plasma membrane. Fur-
ther studies focused on isolating and characterizing the in-
termediates along the alternative pathway will resolve
these issues.
Previous localization studies have indicated that ALP
could follow a different route to the vacuole (Raymond et
al., 1992; Piper et al., 1994). Similarly, indications that
ALP follows a different pathway out of the Golgi have
been extrapolated from differential processing defects of
ALP and soluble vacuolar hydrolases in a number of vps
mutants (Fig. 1) (Herman et al., 1991; Horazdovsky et al.,
1994, 1996; Becherer et al., 1996). However, interpretation
of these processing differences alone may be misleading.
Such differences observed in null mutants may not accu-
rately reflect delivery to the vacuole, as exemplified by the
processing of CPY in vps27D mutants where CPY is pro-
cessed without necessarily reaching the vacuole (Ray-
mond et al., 1992; Piper et al., 1994) (Fig. 1). Also, in vps9
mutant cells, differential kinetic delays in CPY processing
and ALP processing are only seen after rapid inactivation
of temperature-sensitive alleles but not in null mutants
(Burd et al., 1996). Other complications are also evident.
For example, Vps45p is proposed to work in conjunc-
tion with two other class D VPS genes, PEP12/VPS6 (syn-
taxin) and VPS21/YP51 (Rab5) (Singer-Kruger et al., 1994;
Horazdovsky et al., 1994, 1995; Becherer et al., 1996). Like
vps45D cells, pep12D cells and vps21D cells exhibit a punc-
tate vesicular-like labeling pattern for Vph1p, whereas
ALP is clearly localized to the vacuole (Piper, R.C., N.J.
Bryant, and T.H. Stevens, unpublished results). However,
pep12D mutants have been reported to have severe pro-
cessing defects in both ALP and CPY (Becherer et al.,
1996), whereas vps21D/ypt51 mutants have a slight or no
defect in processing of either ALP or CPY (Horazdovsky
et al., 1994; Singer-Kruger et al., 1994). Thus, because of
possible secondary effects due to null mutations, it has not
been possible to conclude confidently that ALP follows a
different pathway to the vacuole. The studies reported
here circumvent these difficulties by using both immuno-
localization and pulse/chase immunoprecipitation techniques
to follow the trafficking of newly synthesized ALP and
two other membrane proteins as they travel to the vacuole
in cells subjected to acute blocks in membrane traffic.
How the Alternative Pathway Might be Controlled
We have characterized a sorting determinant in the cyto-
solic tail of ALP that allows ALP to enter the alternative
Figure 8. Model for the VPS-dependent pathway and the alter-
native bypass pathway to the vacuole. Proteins such as the CPY
receptor and Vph1p enter vesicles in the late Golgi (TGN) of
yeast that fuse with a PVC. This fusion event is controlled by
Vps45p. The CPY receptor then recycles back to the Golgi while
proteins such as Vph1p and CPY are delivered to the vacuole.
These latter steps are controlled by Vps27p. ALP bypasses these
intermediates and neither enters the Vps45p-controlled Golgi-
derived transport vesicles nor transits through the PVC. ALP
may enter a specialized transport vesicle that fuses directly with
the vacuole or may be transported via a yet unidentified interme-
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pathway. This signal acts in a positive fashion to divert
proteins into the alternative pathway that would otherwise
transit through the VPS-dependent pathway. The neces-
sary determinants of the signal itself were found near the
transmembrane domain within amino acids 20–31 of the
NH2-terminal cytosolic tail. It is not yet known which fea-
tures contained in the sequence SRPKKRRISK are neces-
sary for the ALP sorting domain. Although this region is
highly basic, similar stretches of amino acids are found
near the transmembrane domain of the Kex2p, DPAP B,
and Vps10p tails.
We have also found that the syntaxin protein, Vam3p,
also appears to follow a route distinct from the VPS-
dependent pathway since it is localized to the vacuole in
vps27D cells. Further characterization of other proteins
that are transported via the alternative pathway will be
helpful in determining the function of this new post-Golgi
transport step. It is difficult to speculate at this time what
unique function this protein transport pathway provides
that could not otherwise be fulfilled by the VPS-depen-
dent pathway. One possibility is that the alternative path-
way may intersect other transport pathways to the vacuole
such as the autophagy pathway or the process of importing
cytosolic proteins into the vacuole as defined by the CVT
and VID genes (for review see Scott and Klionsky, 1997).
Further studies on the cis-sorting sequence of ALP and
Vam3p may help identify the protein machinery that acts
at the level of the yeast TGN to allow exit via the alterna-
tive pathway. Of particular interest will be characteriza-
tion of the coat proteins responsible for sorting ALP out
of the Golgi. Although the identity of such coat proteins
and associated factors is far from clear, one protein, Vps1p,
does seem directly involved in this process. In cells lacking
Vps1p function, vacuolar proteins that normally route
through the VPS-dependent pathway as well as ALP are
shunted to the cell surface before being endocytosed to
the vacuole (Nothwehr et al., 1995). This is thought to be
due to the inhibition of vesicle formation at the TGN, which
in turn forces proteins into secretory vesicles (Conibear
and Stevens, 1995; Nothwehr et al., 1995). The profound
effect of vps1 mutations on both pathways suggests a dual
role for Vps1p. Importantly, mutations that block the fu-
sion of TGN-derived transport vesicles in the VPS-depen-
dent pathway (Fig. 4) or mutations such as vps34 and
vps15, which are believed to block TGN vesicle formation,
do not appear to divert ALP to the cell surface (Piper,
R.C., and T.H. Stevens, unpublished observations). As a
dynamin homologue, Vps1p is believed to work in the scis-
sion of clathrin-coated pits into coated vesicles (Robinson,
1994; De Camilli et al., 1995), and there is evidence that
loss of clathrin function causes a small amount of ALP to
appear at the cell surface (Seeger and Payne, 1992a). Thus,
there may be two types of clathrin-coated vesicles, each
targeted differently as is the case for clathrin-coated AP-1
and AP-2 vesicles in animal cells (Robinson, 1994). Alter-
natively, given that the effects of clathrin mutations on
ALP trafficking are slight, there may well be an additional
role for Vps1p other than its proposed role with clathrin.
At the other end of the alternative pathway lies the ma-
chinery responsible for the final delivery of ALP to the
vacuole. We found that the vacuolar syntaxin Vam3p may
constitute part of the fusion machinery that is responsible
for the delivery of ALP to the vacuole. Expression of the
cytosolic domain of Vam3p imposed a dominant-interfer-
ing effect and resulted in a significant delay in ALP pro-
cessing. This is consistent with our finding that in vam3
null mutants ALP processing is blocked. We also find that
the VPS-dependent pathway, marked by the processing of
the Vps10p-D10* protein, is also blocked either in vam3D
mutants or in cells carrying the conditional dominant-
interfering VAM3-TMD allele. These data indicate that
Vam3p has a variety of roles by allowing membrane traffic
from a number of different routes to fuse with the vacuole.
These functions would allow the alternative pathway and
the VPS-dependent pathway to converge and to use the
same fusion machinery as that responsible for vacuolar ho-
motypic fusion (Nichols et al., 1997). We have also observed
similar phenotypes in other mutants. For instance, ypt7
mutations block the maturation of ALP (Wichmann et al.,
1992) and our preliminary results with ypt7 and other mu-
tants displaying a class B vps phenotype indicate that the
PEP4-dependent processing of both ALP and Vps10-D10*
is blocked (Bryant, N.J., R.C. Piper, and T.H. Stevens, un-
published observations). Like Vam3p, Ypt7p has an addi-
tional role in vacuolar homotypic fusion (Haas et al., 1995)
and appears to have a role in transport from the late endo-
some to vacuole (Schimmoller and Riezman, 1993). Yet
another protein that may participate in the fusion of ALP-
containing vesicles with the vacuole is the class C Vps pro-
tein, Vps33p/Slp1p, which belongs to the Sec1p family of
proteins and is hypothesized to bind to a t-SNARE–related
protein. vps33 mutants also fail to process ALP (Banta et
al., 1990) and Vps10-D10* (Bryant, N.J., R.C. Piper, and
T.H. Stevens, unpublished observations). One curious fea-
ture of yeast mutants that have blocks in the late stages of
the vacuolar biogenesis pathway (e.g., ypt7 and vam3) is
that intracellular CPY is proteolytically cleaved, whereas
the Vps10p-D10* protein is not (Wichmann et al., 1992;
Nichols et al., 1997; Bryant, N.J., R.C. Piper, and T.H.
Stevens, unpublished observations). This underscores the
difficulty in interpreting the processing of CPY as dis-
cussed above. Exactly where along the vacuolar biogenesis
pathway CPY is matured is not strictly known. One ex-
planation is that CPY could be susceptible to proteases
present in late endosomal compartments, which are likely
to accumulate in some mutants. This is supported by the
observations of Schimmoller and Riezman, who found
that late endosomal compartments isolated from ypt7 mu-
tants contained active vacuolar proteases (Schimmoller and
Riezman, 1993).
The present study has used mutant cells to show that the
pathway taken by ALP to the vacuole is distinct from that
taken by previously well-characterized vacuolar proteins.
Perhaps of greater interest will be determining how the al-
ternative pathway functions in wild-type cells. One focus
for future studies will be to isolate biochemically and char-
acterize the vesicles that carry ALP to the vacuole and to
determine how many sorting steps lie between the TGN
and vacuole within this pathway. Such characterization
will likely elucidate the overall function of this pathway in
eukaryotic cells.
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Note Added in Proof. The identification of an alternative pathway from the
TGN to the vacuole in yeast has recently been reported by Cowles et al.
(Cowles, C.R., W.B. Snyder, C.G. Burd, and S.D. Emr. 1997. Novel Golgi to
vacuole delivery pathway in yeast: identification of a sorting determinant
and required transport component. EMBO (Eur. Mol. Biol. Organ.) J. 16:
2769–2782). The vast majority of our findings are in agreement with this
study, except those concerning the ALP targeting signal. Taken together,
the two studies suggest that the 33–amino acid ALP cytosolic domain may
contain two redundant elements, each sufficient for targeting into the alter-
native pathway.
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